CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 443 filers reported holding CRISPR THERAPEUTICS AG in Q4 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,044,829 | -28.9% | 287,394 | -12.0% | 0.02% | -20.7% |
Q2 2023 | $18,340,852 | +31.3% | 326,698 | +5.8% | 0.03% | +26.1% |
Q1 2023 | $13,968,561 | +32.2% | 308,834 | +18.8% | 0.02% | +27.8% |
Q4 2022 | $10,563,389 | -39.9% | 259,862 | -3.4% | 0.02% | -41.9% |
Q3 2022 | $17,577,000 | +5.7% | 268,992 | -1.7% | 0.03% | +10.7% |
Q2 2022 | $16,636,000 | -51.9% | 273,783 | -50.4% | 0.03% | -36.4% |
Q1 2022 | $34,621,000 | +59.4% | 551,564 | +92.5% | 0.04% | +83.3% |
Q4 2021 | $21,717,000 | – | 286,595 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |